Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Krell

Showing results (31-40 of 135) with videos related to

Pageof 14
Sort By:
Pharmacogenomics|November 23, 2012
Role of miRNAs in the response to anticancer therapyAdam E Frampton, Jonathan Krell, Elisa Giovannetti, et al.
Trends in Microbiology|October 29, 2021
The potential of fecal microbiota transplantation in oncologyMark P Lythgoe, Rohma Ghani, Benjamin H Mullish, et al.
Future Oncology (London, England)|October 11, 2013
Lymph node ratio can further stratify prognosis in subpopulations of breast cancer patients with axillary nodal metastasesAnneliese M Lawn, Adam E Frampton, Jonathan Krell, et al.
Future Oncology (London, England)|December 4, 2013
IDH mutations in tumorigenesis and their potential role as novel therapeutic targetsDaniel Krell, Paul Mulholland, Adam E Frampton, et al.
Trends in Cancer|April 7, 2024
The evolving posology and administration of immune checkpoint inhibitors: subcutaneous formulationsMatthew J Hadfield, David J Benjamin, Jonathan Krell, et al.
Future Oncology (London, England)|February 19, 2013
Circulating molecular markers in pancreatic cancer: ready for clinical use?Tamara M H Gall, Adam E Frampton, Jonathan Krell, et al.
The Lancet Regional Health. Europe|September 23, 2024
Efficacy and safety of interim oncology treatments introduced for solid cancers during the COVID-19 pandemic in England: a retrospective evidence-based analysisMark P Lythgoe, Alica-Joana Emhardt, Huseyin Naci, et al.
Surgery|June 12, 2012
The role of miR-10b in metastatic pancreatic ductal adenocarcinomaAdam E Frampton, Jonathan Krell, Yaojun Zhang, et al.
Expert Review of Anticancer Therapy|December 25, 2012
Altered expression of the miRNA processing endoribonuclease Dicer has prognostic significance in human cancersLoredana Pellegrino, Jimmy Jacob, Laura Roca-Alonso, et al.
Expert Review of Anticancer Therapy|September 21, 2011
Determination of cut-offs for circulating tumor cell measurement in metastatic cancerJimmy Jacob, Jonathan Krell, Leandro Castellano, et al.
Pageof 14

Showing results (31-40 of 135) with videos related to

Sort By:
Pageof 14
Pharmacogenomics|November 23, 2012
Role of miRNAs in the response to anticancer therapyAdam E Frampton, Jonathan Krell, Elisa Giovannetti, et al.
Trends in Microbiology|October 29, 2021
The potential of fecal microbiota transplantation in oncologyMark P Lythgoe, Rohma Ghani, Benjamin H Mullish, et al.
Future Oncology (London, England)|October 11, 2013
Lymph node ratio can further stratify prognosis in subpopulations of breast cancer patients with axillary nodal metastasesAnneliese M Lawn, Adam E Frampton, Jonathan Krell, et al.
Future Oncology (London, England)|December 4, 2013
IDH mutations in tumorigenesis and their potential role as novel therapeutic targetsDaniel Krell, Paul Mulholland, Adam E Frampton, et al.
Trends in Cancer|April 7, 2024
The evolving posology and administration of immune checkpoint inhibitors: subcutaneous formulationsMatthew J Hadfield, David J Benjamin, Jonathan Krell, et al.
Future Oncology (London, England)|February 19, 2013
Circulating molecular markers in pancreatic cancer: ready for clinical use?Tamara M H Gall, Adam E Frampton, Jonathan Krell, et al.
The Lancet Regional Health. Europe|September 23, 2024
Efficacy and safety of interim oncology treatments introduced for solid cancers during the COVID-19 pandemic in England: a retrospective evidence-based analysisMark P Lythgoe, Alica-Joana Emhardt, Huseyin Naci, et al.
Surgery|June 12, 2012
The role of miR-10b in metastatic pancreatic ductal adenocarcinomaAdam E Frampton, Jonathan Krell, Yaojun Zhang, et al.
Expert Review of Anticancer Therapy|December 25, 2012
Altered expression of the miRNA processing endoribonuclease Dicer has prognostic significance in human cancersLoredana Pellegrino, Jimmy Jacob, Laura Roca-Alonso, et al.
Expert Review of Anticancer Therapy|September 21, 2011
Determination of cut-offs for circulating tumor cell measurement in metastatic cancerJimmy Jacob, Jonathan Krell, Leandro Castellano, et al.
Pageof 14